About Evotec
Evotec is a company based in Hamburg (Germany) founded in 1993.. Evotec has raised $25 million across 22 funding rounds from investors including Gates Foundation, Mubadala and 3i Group. The company has 4,830 employees as of December 31, 2024. Evotec has completed 11 acquisitions, including Aptuit, CG Germany and CGC Japan. Evotec offers products and services including PanOmics Platform, CRO/CDMO Services, and iPSC Technologies. Evotec operates in a competitive market with competitors including Crown Bioscience, Alloy Therapeutics, Domainex, NIH and Viva Biotech, among others.
- Headquarter Hamburg, Germany
- Employees 4830 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Evotec Se
-
Annual Revenue
$827.97 M (USD)1.99as on Dec 31, 2024
-
Net Profit
$-203.71 M (USD)-133.67as on Dec 31, 2024
-
EBITDA
$-72.12 M (USD)-869.17as on Dec 31, 2024
-
Total Equity Funding
$25 M (USD)
in 22 rounds
-
Latest Funding Round
-
Investors
Gates Foundation
& 14 more
-
Employee Count
4830
as on Dec 31, 2024
-
Investments & Acquisitions
Aptuit
& 10 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Evotec
Evotec is a publicly listed company on the XETR with ticker symbol EVT in Germany, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Evotec
Evotec offers a comprehensive portfolio of products and services, including PanOmics Platform, CRO/CDMO Services, and iPSC Technologies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-powered platform for analyzing disease data and advancing research.
Services for efficient drug development from concept to clinical stages.
Tools for human-relevant disease modeling and therapeutic testing.
Unlock access to complete
Unlock access to complete
Senior Team
101 people
Software Development Team
53 people
Leadership Team
53 people
Research Team
52 people
Human Resources and Administration
25 people
Finance and Accounting
18 people
Product Management Team
14 people
Principal Team
11 people
Unlock access to complete
Funding Insights of Evotec
Evotec has successfully raised a total of $25M across 22 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 22
- Last Round Last Round
-
First Round
First Round
(30 Mar 1998)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Grant - Evotec | Valuation |
investors |
|
| May, 2025 | Amount | Grant - Evotec | Valuation |
investors |
|
| Jun, 2023 | Amount | Grant - Evotec | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Evotec
Evotec has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation, Mubadala and 3i Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Private equity firm focused on mid-market businesses
|
Founded Year | Domain | Location | |
|
Private equity investments in healthcare companies are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Evotec
Evotec has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include Aptuit, CG Germany and CGC Japan. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs
|
2014 | ||||
|
Developer and producer of cGMP products for cell-gene therapy
|
2009 | ||||
|
Chemical research, production, and development services are provided.
|
2008 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Evotec
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evotec Comparisons
Competitors of Evotec
Evotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Crown Bioscience, Alloy Therapeutics, Domainex, NIH and Viva Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cancer and CVMD drugs are developed using PDX models.
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided for therapeutic development.
|
|
| domain | founded_year | HQ Location |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided to the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Drug discovery and development research services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Evotec
Frequently Asked Questions about Evotec
When was Evotec founded?
Evotec was founded in 1993 and raised its 1st funding round 5 years after it was founded.
Where is Evotec located?
Evotec is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
Is Evotec a funded company?
Evotec is a funded company, having raised a total of $25M across 22 funding rounds to date. The company's 1st funding round was a Grant of $1.7M, raised on Mar 30, 1998.
How many employees does Evotec have?
As of Dec 31, 2024, the latest employee count at Evotec is 4,830.
What is the annual revenue of Evotec?
Annual revenue of Evotec is $827.97M as on Dec 31, 2024.
What does Evotec do?
Evotec was founded in 1993 in Hamburg, Germany, as a provider of drug discovery alliance and development services. Operations focus on supporting the biopharma industry through integrated solutions for target identification, screening, and preclinical advancement. Services encompass chemistry, biology, and informatics platforms, with global collaborations extending beyond Europe to facilitate efficient RD pipelines for pharmaceutical partners.
Who are the top competitors of Evotec?
Evotec's top competitors include Crown Bioscience, NIH and Domainex.
What products or services does Evotec offer?
Evotec offers PanOmics Platform, CRO/CDMO Services, and iPSC Technologies.
Is Evotec publicly traded?
Yes, Evotec is publicly traded on XETR under the ticker symbol EVT.
How many acquisitions has Evotec made?
Evotec has made 11 acquisitions, including Aptuit, CG Germany, and CGC Japan.
Who are Evotec's investors?
Evotec has 15 investors. Key investors include Gates Foundation, Mubadala, 3i Group, CARB-X, and European Union.
What is Evotec's ticker symbol?
The ticker symbol of Evotec is EVT on XETR.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.